Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
Atorvastatin calcium (ATV) and proanthocyanidins (PAC) have a strong antioxidant activity, that can benefit to reduce the atherosclerotic plaque progression. Unfortunately, the bioavailability of ATV is greatly reduced due to its limited drug solubility while the PAC drug is unstable upon exposure t...
Enregistré dans:
| Auteurs principaux: | Maslizan, Mardhiah, Haris, Muhammad Salahuddin, Ajat, Mokrish, Md Jamil, Siti Nurul Ain, Azhar, Shah Christirani, Zahid, N. Idayu, Mat Azmi, Intan Diana |
|---|---|
| Format: | Article |
| Publié: |
Elsevier BV
2024
|
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
par: Maslizan, Mardhiah
Publié: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
par: Maslizan, Mardhiah
Publié: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle /
par: Mardhiah Maslizan, -
Enzyme nanocarriers /
Publié: (2015) -
Nanocarrier Technologies Frontiers of Nanotherapy /
Publié: (2006)
